The Gene Encoding the Hematopoietic Stem Cell Regulator CCN3/NOV is Under Direct Cytokine Control Through the Transcription Factors STAT5A/B

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Aug 20

PMID 20720003

Citations 9

Authors

Akiko Kimura

Cyril Martin

Gertraud W Robinson

James M Simone

Weiping Chen

Mark C Wickre

John J OShea

Lothar Hennighausen

Affiliations

Soon will be listed here.

Abstract

Cytokines control the biology of hematopoietic stem cells (HSCs) and progenitor cells in part through the transcription factors STAT5A/B. To investigate the target genes of STAT5A/B activated by cytokines in HSCs and progenitors, we performed microarray analyses using Lineage(-) Sca-1(+) c-Kit(+) (KSL) cells in the presence and absence of STAT5A/B. Stimulation with a mixture containing IL-3, IL-6, stem cell factor, thrombopoietin, and Flt3 ligand induced Ccn3/Nov mRNA over 100-fold in WT (control) but not Stat5a/b-null KSL cells. CCN3/NOV is a positive regulator of human HSC self-renewal and development of committed blood cells. Without stimulation, the Ccn3/Nov signal level was low in control KSL cells similar to Stat5a/b-null KSL cells. To determine which cytokine activates the Ccn3/Nov gene, we analyzed Lineage(-) c-Kit(+) (KL) and 32D cells using quantitative PCR and ChIP assays. Although stimulation with a mixture lacking IL-3 prevented the induction of Ccn3/Nov in control KL cells, IL-3 alone could induce Ccn3/Nov mRNA in control KL and 32D cells. ChIP assays using 32D cells revealed IL-3-induced binding of STAT5A/B to a γ-interferon-activated sequences site in the Ccn3/Nov gene promoter. This is the first report that Ccn3/Nov is directly induced by cytokines through STAT5A/B.

Citing Articles

Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in -rearranged acute leukemia.

Zhang Q, Falques-Costa T, Pilheden M, Sturesson H, Ovlund T, Rissler V Hemasphere. 2024; 8(9):e70006.

PMID: 39329074 PMC: 11426354. DOI: 10.1002/hem3.70006.

YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis.

Hua Z, Wei R, Guo M, Lin Z, Yu X, Li X Oncogene. 2022; 41(10):1482-1491.

PMID: 35075244 DOI: 10.1038/s41388-022-02191-3.

CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis.

Leguit R, Raymakers R, Hebeda K, Goldschmeding R J Cell Commun Signal. 2021; 15(1):25-56.

PMID: 33428075 PMC: 7798015. DOI: 10.1007/s12079-020-00602-2.

The role of the CCN family of proteins in blood cancers.

Crawford L, Irvine A J Cell Commun Signal. 2016; 10(3):197-205.

PMID: 27485291 PMC: 5055499. DOI: 10.1007/s12079-016-0342-x.

Nov/CCN3 regulates long-term repopulating activity of murine hematopoietic stem cells via integrin αvβ3.

Ishihara J, Umemoto T, Yamato M, Shiratsuchi Y, Takaki S, Petrich B Int J Hematol. 2014; 99(4):393-406.

PMID: 24563081 PMC: 4412171. DOI: 10.1007/s12185-014-1534-x.

References

Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng C . Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol. 2004; 24(18):8037-47. PMC: 515028. DOI: 10.1128/MCB.24.18.8037-8047.2004. View

Perbal B . CCN proteins: multifunctional signalling regulators. Lancet. 2004; 363(9402):62-4. DOI: 10.1016/S0140-6736(03)15172-0. View

Martinerie C, Gicquel C, Louvel A, Laurent M, Schofield P, Le Bouc Y . Altered expression of novH is associated with human adrenocortical tumorigenesis. J Clin Endocrinol Metab. 2001; 86(8):3929-40. DOI: 10.1210/jcem.86.8.7718. View

Hennighausen L, Robinson G . Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev. 2008; 22(6):711-21. PMC: 2394721. DOI: 10.1101/gad.1643908. View

Gupta N, Wang H, McLeod T, Naus C, Kyurkchiev S, Advani S . Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol. 2001; 54(5):293-9. PMC: 1187085. DOI: 10.1136/mp.54.5.293. View

Schuringa J, Chung K, Morrone G, Moore M . Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation. J Exp Med. 2004; 200(5):623-35. PMC: 2212750. DOI: 10.1084/jem.20041024. View

Zhong J, Zhao Y, Sutton S, Su A, Zhan Y, Zhu L . Gene expression profile of murine long-term reconstituting vs. short-term reconstituting hematopoietic stem cells. Proc Natl Acad Sci U S A. 2005; 102(7):2448-53. PMC: 548308. DOI: 10.1073/pnas.0409459102. View

Reindl C, Bagrintseva K, Vempati S, Schnittger S, Ellwart J, Wenig K . Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML. Blood. 2006; 107(9):3700-7. DOI: 10.1182/blood-2005-06-2596. View

Wierenga A, Schepers H, Moore M, Vellenga E, Schuringa J . STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha. Blood. 2006; 107(11):4326-33. DOI: 10.1182/blood-2005-11-4608. View

10.

Kato Y, Iwama A, Tadokoro Y, Shimoda K, Minoguchi M, Akira S . Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis. J Exp Med. 2005; 202(1):169-79. PMC: 2212906. DOI: 10.1084/jem.20042541. View

11.

Sillaber C, Gesbert F, Frank D, Sattler M, Griffin J . STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood. 2000; 95(6):2118-25. View

12.

Huttmann A, Duhrsen U, Heydarian K, Klein-Hitpass L, Boes T, Boyd A . Gene expression profiles in murine hematopoietic stem cells revisited: analysis of cDNA libraries reveals high levels of translational and metabolic activities. Stem Cells. 2006; 24(7):1719-27. DOI: 10.1634/stemcells.2005-0486. View

13.

Schuringa J, Wu K, Morrone G, Moore M . Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo. Stem Cells. 2004; 22(7):1191-204. DOI: 10.1634/stemcells.2004-0033. View

14.

Carlesso N, Frank D, Griffin J . Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med. 1996; 183(3):811-20. PMC: 2192351. DOI: 10.1084/jem.183.3.811. View

15.

Kimura A, Rieger M, Simone J, Chen W, Wickre M, Zhu B . The transcription factors STAT5A/B regulate GM-CSF-mediated granulopoiesis. Blood. 2009; 114(21):4721-8. PMC: 2780307. DOI: 10.1182/blood-2009-04-216390. View

16.

Park I, He Y, Lin F, Laerum O, Tian Q, Bumgarner R . Differential gene expression profiling of adult murine hematopoietic stem cells. Blood. 2002; 99(2):488-98. DOI: 10.1182/blood.v99.2.488. View

17.

Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J . Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol. 1992; 12(1):10-21. PMC: 364064. DOI: 10.1128/mcb.12.1.10-21.1992. View

18.

Schepers H, van Gosliga D, Wierenga A, Eggen B, Schuringa J, Vellenga E . STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells. Blood. 2007; 110(8):2880-8. DOI: 10.1182/blood-2006-08-039073. View

19.

de Groot R, Raaijmakers J, Lammers J, Jove R, Koenderman L . STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells. Blood. 1999; 94(3):1108-12. View

20.

McCallum L, Price S, Planque N, Perbal B, Pierce A, Whetton A . A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood. 2006; 108(5):1716-23. DOI: 10.1182/blood-2006-04-016113. View